Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey

Jakko van Ingen, Stefano Aliberti, Claire Andrejak, James D. Chalmers, Luigi R. Codecasa, Charles L. Daley, Naoki Hasegawa, David E. Griffith, Wouter Hoefsloot, Gwen Huitt, Julie Jarand, Byung Woo Jhun, Michael R. Loebinger, Theodore K. Marras, Kozo Morimoto, Eva Polverino, Felix C. Ringshausen, Miguel Santin, Rachel Thomson, Dirk WagnerRichard J. Wallace, Kevin L. Winthrop, Jae Joon Yim

Research output: Contribution to journalArticlepeer-review

Abstract

Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions.

Original languageEnglish
Pages (from-to)e256-e259
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Volume73
Issue number1
DOIs
Publication statusPublished - Jul 1 2021

Keywords

  • adverse events
  • antibiotic treatment
  • azithromycin
  • Mycobacterium avium complex
  • nontuberculous mycobacteria

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey'. Together they form a unique fingerprint.

Cite this